Why the Cann Group (ASX:CAN) share price is up 76% this week

The Cann Group Ltd (ASX:CAN) share price is surging higher again on Wednesday and is now up 76% since the start of the week…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Cann Group Ltd (ASX: CAN) share price has continued its sensational run and is rocketing higher again on Wednesday.

In afternoon trade the cannabis company's shares are up a further 12% to 56.5 cents.

This means the Cann Group share price is now up an incredible 76% week to date.

Young girl wearing a suit and tie with rocket wings looks to the sky representing the highest traded stocks today

Image source: Getty Images

Why is the Cann Group share price rocketing higher this week?

Investors have been fighting to get hold of the company's shares this week after the release of an update on its debt facility.

On Monday, Cann revealed that it has received credit approval from National Australia Bank (ASX: NAB) for a $50 million secured debt facility.

These funds will be used to complete the first stage of its state-of-the-art medicinal cannabis production site near Mildura. The first stage has an estimated nine month build time, with its first product expected to be processed and released by March 2022.

Once complete, the first stage of the project will provide annual capacity to produce 12,500 kgs of dry flower equivalent.

Work is expected to be underway in February 2021, with the total project cost estimated to be $112 million. Approximately $53 million has already spent on site works and the facility superstructure. The company plans to fund the balance with the new bank loan facility and its current cash reserves.

Why is the Cann Group share price smoking the market today?

There's no point building such an enormous facility if you don't have licences, right?

The good news is that this afternoon the company received notice from the Australian Department of Health's Office of Drug Control (ODC) that its existing licences (for cultivation and production of medicinal cannabis, research activities in relation to medicinal cannabis, and manufacture of medicinal cannabis products) can be extended to its new Mildura facility.

Each ODC Licence includes a condition that Cann Group must provide the ODC with evidence that an independent security assessment has been undertaken on the Mildura facility, once it has been constructed.

Cann Group's CEO, Peter Crock, believes that in addition to having the finance in place to build the state-of-the-art facility near Mildura, having the requisite licences in place will enable the Mildura facility's production to come on-line from a regulatory perspective.

He commented: "The variation to our licences will enable us to proceed with certainty in respect of the building of the facility and moving into cultivation, production and manufacture from the facility seamlessly. We are on track to be processing and releasing material from our Mildura facility by the end of the first quarter of calendar year 2022."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a group of business people sit dejectedly around a table, each expressing desolation, sadness and disappointment by holding their head in their hands, casting their gazes down and looking very glum.
Share Fallers

DroneShield shares tumble 17% as CEO exit revives leadership fears

Investors bank gains as DroneShield leadership reset unsettles sentiment...

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Domino's and Pro Medicus shares

A leading analyst expects Domino’s and Pro Medicus shares to keep underperforming.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Coles, Endeavour, and Rio Tinto shares

The team at Morgans has given its verdict on these popular shares.

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Morgans names two ASX 200 shares to buy and one to sell this week

Let's see which shares Morgans is bullish and bearish on this week.

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Broker Notes

Why beaten down CSL shares now offer 'long-term appeal'

A leading expert gives his outlook for CSL’s beaten down shares.

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 compelling reasons to buy QBE shares today

A top expert forecasts more outperformance from QBE shares.

Read more »

Falling prices of oil demonstrated by a red arrow and barrels of oil.
Energy Shares

ASX shares to watch as oil price crashes

The turnaround in oil prices is a huge headwind for the ASX shares.

Read more »